Pemira Sells Althea Group to DWS and F2i
Posted on 05/12/2022
On May 11, 2022, Permira Funds agreed to sell Althea Group S.p.A., a provider of technology management services to the European healthcare industry, to a consortium formed by F2i Sgr 9Fondi italiani per le infrastrutture), Italy’s largest independent infrastructure fund manager, and DWS, via its portfolio company Inframedica. F2i SGR has assets under management of over 6 billion euros.
Althea was originally established in 2014 through the combination of MESA in Switzerland and Asteral in the U.K., followed by the IBSL Group and TBS in Italy, with the vision to create the leading independent medical equipment service provider, allowing hospitals to benefit from integrated, vendor-neutral and high-quality service at an affordable cost. Through consolidation, Althea has brought together healthcare businesses with highly skilled management teams across Europe to build a platform with unique capabilities and differentiated positioning to partner with hospitals and clinics.
Currently, Althea serves over 2,700 healthcare facilities across 18 countries, with 3,000+ employees managing over 1.4 million medical devices.
Advisors
The Permira Funds were advised by Rothschild & Co, EY, Giliberti and Triscornia e Associati.
F2i SGR was advised in the transaction by: Mediobanca (financial advisors), Clifford Chance (legal and tax advisors); Studio Legale Pedersoli (legal advisors); Goetzpartners (industrial advisors), PWC (accounting and ESG advisors); Marsh (insurance advisors).